The Next Generation Sequencing market is categorized by product (software and services) and by applications. By product it is sub segmented into whole targeted re-sequencing, genome sequencing, exome sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq. By application it is sub segmented into diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture & animal research. On the basis of geography, the Latin America Market is segmented into Argentina, Brazil, Mexico and Rest of Latin America.
The Latin America NGS Market which as worth USD 0.29 billion in 2018 is expected to reach USD 0.7 billion by 2023 at a CAGR of 19.06%.
Rise in growth of personalized medicine, development in pre-sequencing and NGS bioinformatics solutions and cloud computing, increased application of NGS, growth in population, increasing incidences of infectious diseases are few factors driving the market growth. In addition, anticipated decrease in the prices of genome sequencing due to development of rapid, high capacity whole genome sequencers by key players is anticipated to have an optimistic effect on market penetration rates over the next few years. However, the storage and management of data generated by sequencing and its interpretation,high reliability on grants & funding from the government and fall in capital expenditure from academic institutions are some of the challenges faced by Latin America next generation sequencing market
Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche),Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc.,Partek Inc., Genomatix Software GmbH, Perkin Elmer inc.,GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd.,Pacific Biosciences, DNASTAR Inc., Knome Inc., Illumina Inc., and Qiagen N.V.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Software
5.1.2 Services
5.2 By Technology
5.2.1 Whole Targeted Re-Sequencing
5.2.2 Genome Sequencing
5.2.3 De Novo Sequencing
5.2.4 Exome Sequencing
5.2.5 RNA-Seq
5.2.6 ChIP-Seq
5.2.7 Methyl-Seq
5.3 By Application
5.3.1 Diagnostics
5.3.2 Drug Discovery
5.3.3 Biomarker Discovery
5.3.4 Personalized Medicine
5.3.5 Agriculture and Animals Research
6. Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Argentina
6.4 Mexico
6.5 Rest of Latin America
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Macrogen Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Thermo Fischer Scientific
8.3 Life Sciences (Roche)
8.4 Pacific Biosciences
8.5 Life Technologies Corp.
8.6 Partek Inc.
8.7 Genomatix Software GmbH
8.8 Perkin Elmer inc.
8.9 GATC Biotech Ag
8.10 Agilent Technologies Inc.
8.11 Biomatters Ltd.
8.12 CLC Bio (Qiagen)
8.13 Pacific Biosciences
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
